140 related articles for article (PubMed ID: 26378075)
1. Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells.
Manlove LS; Berquam-Vrieze KE; Pauken KE; Williams RT; Jenkins MK; Farrar MA
J Immunol; 2015 Oct; 195(8):4028-37. PubMed ID: 26378075
[TBL] [Abstract][Full Text] [Related]
2. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
Volpe G; Cignetti A; Panuzzo C; Kuka M; Vitaggio K; Brancaccio M; Perrone G; Rinaldi M; Prato G; Fava M; Geuna M; Pautasso M; Casnici C; Signori E; Tonon G; Tarone G; Marelli O; Fazio VM; Saglio G
Cancer Res; 2007 Jun; 67(11):5300-7. PubMed ID: 17545610
[TBL] [Abstract][Full Text] [Related]
3. T-cell immunity to oncogenic proteins including mutated ras and chimeric bcr-abl.
Cheever MA; Chen W; Disis ML; Takahashi M; Peace DJ
Ann N Y Acad Sci; 1993 Aug; 690():101-12. PubMed ID: 8103658
[TBL] [Abstract][Full Text] [Related]
4. Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11).
Mundhada S; Luthra R; Cano P
BMC Cancer; 2004 Jun; 4():25. PubMed ID: 15202948
[TBL] [Abstract][Full Text] [Related]
5. Leukemia-associated fusion proteins, dek-can and bcr-abl, represent immunogenic HLA-DR-restricted epitopes recognized by fusion peptide-specific CD4+ T lymphocytes.
Makita M; Azuma T; Hamaguchi H; Niiya H; Kojima K; Fujita S; Tanimoto M; Harada M; Yasukawa M
Leukemia; 2002 Dec; 16(12):2400-7. PubMed ID: 12454745
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a monoclonal antibody specific for novel Bcr/Abl out-of-frame fusion proteins.
Casnici C; Volpe G; Crotta K; Panuzzo C; Lattuada D; Cabras CA; Longhi R; Saglio G; Marelli O
Hybridoma (Larchmt); 2011 Jun; 30(3):261-9. PubMed ID: 21707361
[TBL] [Abstract][Full Text] [Related]
7. Immunologic evaluation of peptides derived from BCR/ABL-out-of-frame fusion protein in HLA A2.1 transgenic mice.
Casnici C; Volpe G; Crotta K; Lattuada D; Saglio G; Marelli O
J Immunother; 2012 May; 35(4):321-8. PubMed ID: 22495389
[TBL] [Abstract][Full Text] [Related]
8. Role of Vitamins A and D in BCR-ABL Arf
Annu K; Cline C; Yasuda K; Ganguly S; Pesch A; Cooper B; Janke L; Payton M; Mukherjee K; Surman SL; Hurwitz JL; Schuetz EG
Sci Rep; 2020 Feb; 10(1):2359. PubMed ID: 32047189
[TBL] [Abstract][Full Text] [Related]
9. Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells.
Zeng Y; Graner MW; Thompson S; Marron M; Katsanis E
Blood; 2005 Mar; 105(5):2016-22. PubMed ID: 15374884
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo priming of CD4 T cells converts immunological tolerance into effective antitumor immunity in a murine model of acute lymphoblastic leukemia.
Hegazy AN; Klein C
Leukemia; 2008 Nov; 22(11):2070-9. PubMed ID: 18633431
[TBL] [Abstract][Full Text] [Related]
11. Peptides derived from the whole sequence of BCR-ABL bind to several class I molecules allowing specific induction of human cytotoxic T lymphocytes.
Buzyn A; Ostankovitch M; Zerbib A; Kemula M; Connan F; Varet B; Guillet JG; Choppin J
Eur J Immunol; 1997 Aug; 27(8):2066-72. PubMed ID: 9295046
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the CDR3 structure of the Vβ21 T cell clone in patients with P210(BCR-ABL)-positive chronic myeloid leukemia and B-cell acute lymphoblastic leukemia.
Zha X; Chen S; Yang L; Li B; Chen Y; Yan X; Li Y
Hum Immunol; 2011 Oct; 72(10):798-804. PubMed ID: 21820025
[TBL] [Abstract][Full Text] [Related]
13. Curcumin inhibits proliferation and induces apoptosis of leukemic cells expressing wild-type or T315I-BCR-ABL and prolongs survival of mice with acute lymphoblastic leukemia.
William BM; Goodrich A; Peng C; Li S
Hematology; 2008 Dec; 13(6):333-43. PubMed ID: 19055861
[TBL] [Abstract][Full Text] [Related]
14. T-cell immunity to the joining region of p210BCR-ABL protein.
Chen W; Peace DJ; Rovira DK; You SG; Cheever MA
Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1468-72. PubMed ID: 1346932
[TBL] [Abstract][Full Text] [Related]
15. Prevention and synergistic control of Ph(+) ALL by a DNA vaccine and 6-mercaptopurine.
Köchling J; Rott Y; Arndt S; Marschke C; Schmidt M; Wittig B; Kalies K; Westermann J; Henze G
Vaccine; 2012 Sep; 30(41):5949-55. PubMed ID: 22841975
[TBL] [Abstract][Full Text] [Related]
16. BCR-ABL fusion regions as a source of multiple leukemia-specific CD8+ T-cell epitopes.
Kessler JH; Bres-Vloemans SA; van Veelen PA; de Ru A; Huijbers IJ; Camps M; Mulder A; Offringa R; Drijfhout JW; Leeksma OC; Ossendorp F; Melief CJ
Leukemia; 2006 Oct; 20(10):1738-50. PubMed ID: 16932347
[TBL] [Abstract][Full Text] [Related]
17. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen JW; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram CR; Ludwig WD; Riehm H; Lampert F; Harbott J
Leukemia; 1996 Jun; 10(6):957-63. PubMed ID: 8667652
[TBL] [Abstract][Full Text] [Related]
18. Clonal characteristics of acute lymphoblastic cells derived from BCR/ABL p190 transgenic mice.
Griffiths SD; Healy LE; Ford AM; Bennett CA; Voncken JW; Heisterkamp N; Groffen J; Greaves MF
Oncogene; 1992 Jul; 7(7):1391-9. PubMed ID: 1377812
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
[TBL] [Abstract][Full Text] [Related]
20. Antibody recognition of the tumor-specific b3-a2 junction of bcr-abl chimeric proteins in Philadelphia-chromosome-positive leukemias.
van Denderen J; ten Hacken P; Berendes P; Zegers N; Boersma W; Grosveld G; van Ewijk W
Leukemia; 1992 Nov; 6(11):1107-12. PubMed ID: 1434792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
